Requires prescribers to discuss opioid risks and alternatives with patients before prescribing.
Mississippi HB956 mandates that prescribers discuss the risks of opioid drugs and available alternatives with patients before issuing the initial and third prescriptions in a treatment course for acute or chronic pain. The discussion must cover addiction risks, reasons for the prescription, and alternative treatments. The bill also outlines rules for valid prescriptions and controlled substance schedules.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.